Tri Locum Partners LP Aclaris Therapeutics, Inc. Transaction History

Tri Locum Partners LP

  • $374 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$9.74 - $17.92 $539,917 - $993,359
-55,433 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.49 $680,162 - $1.02 Million
55,433 New
55,433 $806,000
Q2 2021

Aug 16, 2021
SELL
$17.08 - $29.6 $2.8 Million - $4.86 Million
-164,199 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$5.86 - $27.73 $962,206 - $4.55 Million
164,199 New
164,199 $4.14 Million

Others Institutions Holding ACRS

# of Institutions
85
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $137M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email